FINANCIAL INSTRUMENTS - Cash Flow Hedges (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Gain (loss) recognized in AOCI | $ (313) | $ 47 |
Gain (loss) reclassified from AOCI into earnings | (59) | 0 |
Pre-tax loss included in AOCI related to cash flow hedges of forecasted transactions | 183 | $ 0 |
Amount of loss expected to be transferred to earnings as an expense | $ 125 | |
Maximum term of hedged forecasted transactions | 15 years | 14 years |
Disposed of by sale | BioPharma | ||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||
Pre-tax loss included in AOCI related to cash flow hedges of forecasted transactions | $ 18 |